Publicaciones en las que colabora con F. Fernández Avilés (83)

2024

  1. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

2023

  1. Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 7

  2. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  3. Machine Learning to Optimize the Echocardiographic Follow-Up of Aortic Stenosis

    JACC: Cardiovascular Imaging, Vol. 16, Núm. 6, pp. 733-744

2022

  1. Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial

    European Heart Journal, Vol. 43, Núm. 29, pp. 2783-2797

  2. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

    Journal of the American College of Cardiology, Vol. 79, Núm. 15, pp. 1441-1453

  3. VA-ECMO support in patients with refractory cardiogenic shock. A 6-year multicenter registry

    REC: CardioClinics, Vol. 57, Núm. 1, pp. 7-13

2021

  1. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105

  2. Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival

    Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21

  3. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

  4. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

2020

  1. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

    Open Heart, Vol. 7, Núm. 2

  2. Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics

    Canadian Journal of Cardiology, Vol. 36, Núm. 10, pp. 1624-1632

2018

  1. Safety and efficacy of cryoablation vs. radiofrequency ablation of septal accessory pathways: Systematic review of the literature andmeta-analyses

    Europace, Vol. 20, Núm. 8, pp. 1334-1342

  2. Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with st-segment elevation myocardial infarction and left ventricular dysfunction a multicenter randomized, double-blind, and placebo-controlled clinical trial

    Circulation Research, Vol. 123, Núm. 5, pp. 579-589

  3. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

2017

  1. Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis

    American Heart Journal, Vol. 193, pp. 46-54

  2. The Functional Significance of Paradoxical Low-Gradient Aortic Valve Stenosis: Hemodynamic Findings During Cardiopulmonary Exercise Testing

    JACC: Cardiovascular Imaging, Vol. 10, Núm. 1, pp. 29-39

2016

  1. Cell expansion-dependent inflammatory and metabolic profile of human bone marrow mesenchymal stem cells

    Frontiers in Physiology, Vol. 7, Núm. NOV

  2. Data from acellular human heart matrix

    Data in Brief